Joinn Laboratories(China)Co.,Ltd. (SHA:603127)
42.57
-1.17 (-2.67%)
Sep 10, 2026, 3:00 PM CST
SHA:603127 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 28,685 | 23,924 | 11,374 | 16,313 | 29,328 | 40,246 | |
Market Cap Growth | 19.87% | 110.35% | -30.28% | -44.38% | -27.13% | 71.60% |
Enterprise Value | 26,315 | 20,564 | 8,211 | 13,257 | 26,217 | 35,556 |
Last Close Price | 42.57 | 34.90 | 16.57 | 23.35 | 40.64 | 57.19 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 31.89 | 80.33 | 153.54 | 41.09 | 27.30 | 72.20 |
Forward PE | 42.20 | 75.53 | 47.64 | 19.41 | 30.58 | 77.82 |
PS Ratio | 16.94 | 14.43 | 5.64 | 6.86 | 12.93 | 26.54 |
PB Ratio | 3.20 | 2.87 | 1.41 | 1.97 | 3.58 | 5.63 |
P/TBV Ratio | 3.32 | 3.00 | 1.49 | 2.08 | 3.67 | 5.85 |
P/FCF Ratio | 101.24 | 79.49 | 163.56 | 37.92 | 43.34 | 89.75 |
P/OCF Ratio | 38.82 | 53.81 | 33.56 | 26.19 | 31.02 | 58.70 |
PEG Ratio | - | 1.70 | 3.41 | 1.98 | 0.73 | 3.22 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 15.54 | 12.41 | 4.07 | 5.58 | 11.56 | 23.44 |
EV/EBITDA Ratio | - | - | 44.31 | 19.60 | 32.66 | 72.52 |
EV/EBIT Ratio | - | - | 98.11 | 23.13 | 37.01 | 85.51 |
EV/FCF Ratio | 92.88 | 68.33 | 118.08 | 30.82 | 38.74 | 79.29 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
Debt / EBITDA Ratio | 0.19 | 2.89 | 0.28 | 0.10 | 0.11 | 0.19 |
Debt / FCF Ratio | 0.04 | 0.07 | 0.88 | 0.16 | 0.13 | 0.21 |
Net Debt / Equity Ratio | -0.26 | -0.41 | -0.37 | -0.57 | -0.40 | -0.66 |
Net Debt / EBITDA Ratio | -72.20 | 138.72 | -16.35 | -6.95 | -4.04 | -9.67 |
Net Debt / FCF Ratio | -8.37 | -11.30 | -43.58 | -10.93 | -4.79 | -10.57 |
Asset Turnover | 0.17 | 0.17 | 0.21 | 0.23 | 0.24 | 0.28 |
Inventory Turnover | 0.79 | 0.95 | 0.90 | 1.24 | 2.18 | 1.41 |
Quick Ratio | 1.68 | 3.24 | 3.09 | 3.49 | 2.00 | 4.16 |
Current Ratio | 4.05 | 4.53 | 4.53 | 4.85 | 3.22 | 4.79 |
Return on Equity (ROE) | 11.53% | 3.63% | 0.85% | 4.75% | 14.00% | 13.30% |
Return on Assets (ROA) | -0.46% | -0.84% | 0.54% | 3.51% | 4.69% | 4.88% |
Return on Invested Capital (ROIC) | -1.13% | -2.28% | 1.30% | 10.38% | 16.68% | 23.21% |
Return on Capital Employed (ROCE) | -0.80% | -1.50% | 1.00% | 6.70% | 8.30% | 5.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.43% | 1.24% | 0.65% | 2.43% | 3.66% | 1.39% |
FCF Yield | 0.99% | 1.26% | 0.61% | 2.64% | 2.31% | 1.11% |
Dividend Yield | 0.27% | 0.34% | 0.18% | 0.69% | 0.70% | 0.32% |
Payout Ratio | 9.92% | 7.52% | 161.50% | 53.99% | 12.79% | 17.09% |
Buyback Yield / Dilution | 2.00% | -0.52% | 1.11% | 0.33% | -3.03% | -16.95% |
Total Shareholder Return | 2.27% | -0.18% | 1.29% | 1.01% | -2.33% | -16.63% |